SOUTH KOREA · OPENDART
PharmGen Science, Inc.
팜젠사이언스 · 004720 · KOSPI · Healthcare · Drug Manufacturers—General
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
No exchange purchase by an insider is on record yet.
Other changes in holdings · 36
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-05-11 | Han Dae-hui | Executive | Acquisition of shares upon exercise of call option(+) | 269,179 | DART ↗ |
| 2026-05-11 | Han Dae-hui | Executive | Conversion, etc.(-) | 269,179 | DART ↗ |
| 2026-05-11 | Han Dae-hui | Executive | Exercise of convertible bond rights(+) | 269,179 | DART ↗ |
| 2025-12-11 | Han Ui-sang | Chairman | Conversion, etc.(-) | 2,056,555 | DART ↗ |
| 2025-12-11 | Han Ui-sang | Chairman | Exercise of convertible bond rights(+) | 2,056,555 | DART ↗ |
| 2025-12-11 | Yoo Jae-man | Auditor | Exercise of convertible bond rights(+) | 514,138 | DART ↗ |
| 2025-12-11 | Yoo Jae-man | Auditor | Conversion, etc.(-) | 514,138 | DART ↗ |
| 2025-12-11 | Park Sang-hyeon | Executive | Conversion, etc.(-) | 51,412 | DART ↗ |
| 2025-12-11 | Park Sang-hyeon | Executive | Exercise of convertible bond rights(+) | 51,413 | DART ↗ |
| 2025-12-11 | Bae Jeong-ik | Executive | Conversion, etc.(-) | 25,706 | DART ↗ |
| 2025-12-11 | Bae Jeong-ik | Executive | Exercise of convertible bond rights(+) | 25,706 | DART ↗ |
| 2025-06-11 | Park Sang-hyeon | Executive | Others(+) | 25,706 | DART ↗ |
| 2025-04-11 | Han Ui-sang | Chairman | Exercise price adjustment | 180,823 | DART ↗ |
| 2025-04-11 | Bae Jeong-ik | Executive | Exercise price adjustment | 2,260 | DART ↗ |
| 2025-04-11 | Park Sang-hyeon | Executive | Exercise price adjustment | 2,260 | DART ↗ |
| 2025-04-11 | Yoo Jae-man | Auditor | Exercise price adjustment | 45,205 | DART ↗ |
| 2025-03-31 | Yoo Jae-man | Auditor | New report(+) | 35,992 | DART ↗ |
| 2025-03-31 | Yoo Jae-man | Auditor | New report(+) | 468,933 | DART ↗ |
| 2025-03-11 | Han Ui-sang | Chairman | Exercise price adjustment | 36,652 | DART ↗ |
| 2025-03-11 | Bae Jeong-ik | Executive | Exercise price adjustment | 458 | DART ↗ |
| 2025-03-11 | Park Sang-hyeon | Executive | Exercise price adjustment | 458 | DART ↗ |
| 2025-02-11 | Han Ui-sang | Chairman | Exercise price adjustment | 16,757 | DART ↗ |
| 2025-02-11 | Bae Jeong-ik | Executive | Exercise price adjustment | 209 | DART ↗ |
| 2025-02-11 | Park Sang-hyeon | Executive | Exercise price adjustment | 209 | DART ↗ |
| 2024-12-11 | Han Ui-sang | Chairman | 행사가액조정 | 186,332 | DART ↗ |
| 2024-12-11 | Lee Hae-du | Executive | 행사가액조정 | 4,659 | DART ↗ |
| 2024-12-11 | Bae Jeong-ik | Executive | 행사가액조정 | 2,330 | DART ↗ |
| 2024-12-11 | Park Sang-hyeon | Executive | 행사가액조정 | 2,330 | DART ↗ |
| 2024-11-11 | Han Ui-sang | Chairman | 행사가액조정 | 9,975 | DART ↗ |
| 2024-11-11 | Lee Hae-du | Executive | 행사가액조정 | 249 | DART ↗ |
| 2024-11-11 | Bae Jeong-ik | Executive | 행사가액조정 | 124 | DART ↗ |
| 2024-11-11 | Park Sang-hyeon | Executive | 행사가액조정 | 124 | DART ↗ |
| 2024-10-11 | Han Ui-sang | Chairman | 행사가액조정 | 35,559 | DART ↗ |
| 2024-10-11 | Lee Hae-du | Executive | 행사가액조정 | 889 | DART ↗ |
| 2024-10-11 | Bae Jeong-ik | Executive | 행사가액조정 | 445 | DART ↗ |
| 2024-10-11 | Park Sang-hyeon | Executive | 행사가액조정 | 445 | DART ↗ |